Children under 5 with RSV or flu face higher bacteremia risk if febrile, under 6 months, or need respiratory support, with ...

Seven days of antibiotics was noninferior to 14 days for treating Gram-negative bloodstream infections, supporting shorter ...

Rhubarb could help battle deadly antibiotic-resistant superbugs such as E. coli, suggests new research. Natural compounds ...

Remnants of everything that humans ingest ends up in waste water, including medications that people may be taking, like ...

Antimicrobial resistance not only undermines the efficacy of current treatments but also endangers the entirety of modern ...

Picking up where traditional antibiotics are failing, two natural compounds have been shown effective in killing ...

Closely related bacterial species use different strategies to build their cell walls, an international team of scientists led ...

Flightpath Biosciences, Inc., a clinical stage biotechnology company focused on the development of precision therapeutics targeting bacterial ...

Global Sepsis Treatment Market Report: Growth, Expansion, and Strategic Insights (2025–2033) The Global Sepsis Treat ...

ORLYNVAHTM is a novel oral penem antibiotic for the treatment of uUTIs. ORLYNVAHTM possesses potent activity against species of Enterobacterales including those that encode extended spectrum ...

Basel-based BioVersys stands to receive CHF 5 million upfront under the terms of the deal, which could be worth up to CHF 479 ...

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the United States Patent and Trademark ...